default author photo

Feng-Cai Zhu

Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology

Nanjing

China

  • Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology

SCHOLARLY PAPERS

10

DOWNLOADS

1,947

TOTAL CITATIONS

10

Scholarly Papers (10)

Actions:
Email selected abstracts
1.

Immunogenicity and Safety of BNT162b2 mRNA Vaccine in Chinese Adults: A Randomized Clinical Trial

Number of pages: 35 Posted: 19 May 2022
Ai-Min Hui, Jing-Xin Li, Li Zhu, Rong Tang, Huayue Ye, Mei Lin, Lei Ge, Xiyuan Wang, Fuzhong Peng, Zhenggang Wu, Xi-Ling Guo, Yunfeng Shi, Hong-Xing Pan, Jiahong Zhu, Zhizhou Song, Jingjun Qiu, Wei Wang, Jianfei Zheng, Orkun Ozhelvaci, Svetlana Shpyro, Meghan Bushway, Evelyna Derhovanessian, Marie-Cristine Kühnle, Ulrich Luxemburger, Alexander Muik, Yoana Shishkova, Zakaria Khondker, Simin Hu, Eleni Lagkadinou, Uğur Şahin, Özlem Türeci and Feng-Cai Zhu
Fosun Pharma (USA), Nanjing Medical University, Taizhou People’s Hospital, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Taizhou Vaccine Clinical Research Center, Taizhou People’s Hospital, Fosun Pharma (China), Fosun Pharma (China), Taizhou Vaccine Clinical Research Center, Taizhou People’s Hospital, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, Lianshui Center for Disease Control and Prevention, Fosun Pharma (China), Fosun Pharma (China), Fosun Pharma (China), BioNTech (Germany), BioNTech (Germany), BioNTech (USA), Fosun Pharma (China), BioNTech (Germany), BioNTech (Germany), BioNTech (Germany), BioNTech (Germany), BioNTech (USA), BioNTech (USA), BioNTech (Germany), BioNTech (Germany), BioNTech (Germany) and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 549 (125,837)
Citation 1

Abstract:

Loading...

BNT162b2 mRNA vaccine, COVID-19, intramuscular injection, messenger RNA, neutralizing antibodies, SARS-CoV-2, vaccination

2.

Safety and Immunogenicity of Heterologous Boost Immunisation With an Aerosolized Ad5-nCoV After Two-Dose Priming With an Inactivated SARS-CoV-2 Vaccine CoronaVac in Adults: A Randomised, Open-Label, Parallel-Control Trial

Number of pages: 26 Posted: 04 Jan 2022
Jing-Xin Li, Shi-Po Wu, Xi-Ling Guo, Rong Tang, Bao-Ying Huang, Xiao-Qin Chen, Hai-Tao Huang, Yin Chen, Li-Hua Hou, Jin-Bo Gou, Jing-Xian Liu, Wei-Xue Si, Jin Zhong, Xue Wang, Hong-Xing Pan, Feng-Juan Shi, Xiao-Long Zhao, Xiao-Yu Xu, Zhuo-Pei Li, Xiao-Yin Zhang, Lun-Biao Cui, Tao Zhu, Wen-Jie Tan, Wei Chen and Feng-Cai Zhu
Nanjing Medical University, Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Chinese Center for Disease Control and Prevention (China CDC) - NHC Key Laboratory of Biosafety, Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Nanjing Vazyme Biotech Co., Ltd., Nanjing Medical University - School of Public Health, Southeast University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Chinese Center for Disease Control and Prevention (China CDC) - NHC Key Laboratory of Biosafety, Academy of Military Medical Sciences - Institute of Biotechnology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 456 (157,043)
Citation 1

Abstract:

Loading...

Heterologous boost, aerosolized adenovirus type-5 vector-based COVID-19 vaccine, safety, immunogenicity, inactivated COVID-19 vaccine, clinical trial

3.

Safety, Immunogenicity and Efficacy of the mRNA Vaccine CS-2034 as a Heterologous Booster Versus Homologous Booster with BBIBP-CorV in Adults Aged ≥18 Years: A Randomized, Partial-Blind, Phase 2b Trial

Number of pages: 25 Posted: 15 Feb 2023
Jundong Wu, Jing-Xin Li, Jian Liu, Haomeng Wang, Guanghui Zhou, Jin Li, Dou Wu, Xiang Chen, Yan Feng, Ying Wang, Xiaoyuan Qi, Xue Wang, Xiaomin Ma, Jin-Bo Gou, Tieliang Ma, Xiaoyun Yang, Lifeng Xu, Peng Wan, Tao Zhu, Zhongfang Wang and Feng-Cai Zhu
Yixing People's Hospital, Nanjing Medical University, CanSino Biologics Inc., CanSino Biologics Inc., Yixing People's Hospital, CanSino Biologics Inc., CanSino Biologics Inc., Yixing People's Hospital, Yixing People's Hospital, CanSino Biologics Inc., Yixing People's Hospital, CanSino Biologics Inc., CanSino Biologics Inc., CanSino Biologics Inc., CanSino Biologics Inc., Guangzhou Laboratory, CanSino Biologics Inc., CanSino Biologics Inc., CanSino Biologics Inc., Guangzhou Medical University - State Key Laboratory of Respiratory Disease and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 228 (336,244)

Abstract:

Loading...

SARS-CoV-2, Omicron, heterologous booster, homologous booster, mRNA vaccine CS-2034, safety, immunogenicity

4.

Safety and Immunogenicity of Aerosolised Ad5-nCoV or Intramuscular Ad5-nCoV or Inactivated COVID-19 Vaccine Coronavac Given as the Second Booster Following Three Doses of CoronaVac: A Multicentre, Open-Label, Phase 4, Randomized Trial

Number of pages: 24 Posted: 30 Dec 2022
Rong Tang, Hui Zheng, Bu-Sen Wang, Jin-Bo Gou, Xi-Ling Guo, Xiao-Qin Chen, Hai-Tao Huang, Yin Chen, Shi-Po Wu, Xiaolong Li, Jin Zhong, Xue Wang, Hong-Xing Pan, Jiahong Zhu, Peng Wan, Xiao-Yu Xu, Feng-Juan Shi, Zhuo-Pei Li, Jing-Xian Liu, Xiao-Yin Zhang, Lun-Biao Cui, Zhizhou Song, Tao Zhu, Li-Hua Hou, Feng-Cai Zhu and Jing-Xin Li
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Southeast University - School of Public Health, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, CanSino Biologics Inc., Nanjing Vazyme Biotech Co., Ltd., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Nanjing Medical University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Southeast University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, CanSino Biologics Inc., Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology and Nanjing Medical University
Downloads 157 (477,517)

Abstract:

Loading...

5.

Safety, Tolerability and Immunogenicity of a Recombinant Adenovirus Type 5 Vectored COVID-19 Vaccine in Healthy Adults in China: Preliminary Report of a First-In Human Single-Center, Open-Label, Dose-Escalating Clinical Trial

Number of pages: 21 Posted: 17 Jun 2020
Feng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, Li-Hua Hou, Wen-Juan Wang, Jingxin Li, Shi-Po Wu, Bu-Sen Wang, Zhao Wang, Lei Wang, Si-Yue Jia, Hu-Dachuan Jiang, Ling Wang, Tao Jiang, Yi Hu, Jing-Bo Gou, Shabei Xu, Jun-Jie Xu, Xue-Wen Wang, Wei Wang and Wei Chen
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Independent, Independent, Independent, Independent, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Huazhong University of Science and Technology - Department of Neurology, Independent, Independent, Huazhong University of Science and Technology - Department of Neurology and Academy of Military Medical Sciences - Institute of Biotechnology
Downloads 144 (514,995)
Citation 7

Abstract:

Loading...

COVID-19; Vaccine; SARS-CoV-2; Clinical trial

6.

Safety and Immunogenicity of Heterologous Boosting With a Protein-Subunit-Based COVID-19 Vaccine (ZF2001) in Healthy Adults Previously Received One Dose of Convidecia: A Randomised, Observer-Blinded, Placebo-Controlled Trial

Number of pages: 36 Posted: 10 Jan 2022
Pengfei Jin, Xi-Ling Guo, Wei Chen, Shihua Ma, Hong-Xing Pan, Lianpan Dai, Pan Du, Lili Wang, Lairun Jin, Yin Chen, Feng-Juan Shi, Jing-Xian Liu, Xiao-Yu Xu, Yanan Zhang, George F. Gao, Cancan Chen, Jialu Feng, Jing-Xin Li and Feng-Cai Zhu
Chinese Center for Disease Control and Prevention (China CDC) - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Chinese Center for Disease Control and Prevention (China CDC) - Guanyun County Center for Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Nanjing Vazyme Biotech Co., Ltd., Chinese Center for Disease Control and Prevention (China CDC) - Guanyun County Center for Disease Control and Prevention, Southeast University, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Nanjing Vazyme Biotech Co., Ltd., Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Nanjing Medical University, Nanjing Medical University and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 118 (604,538)

Abstract:

Loading...

SARS-CoV-2, heterologous immunisation, recombinant adenovirus type-5-vectored COVID-19 vaccine, protein-subunit-based COVID-19 vaccine, clinical trial

7.

Safety, Immunogenicity and Efficacy of Heterologous Boost with an Aerosolized Ad5-nCoV after Two-Dose Priming with Inactivated COVID-19 Vaccines in Adults: A Multicenter, Open-Label Trial

Number of pages: 25 Posted: 07 Apr 2023
Jing-Xin Li, Li-Hua Hou, Jin-Bo Gou, Si-Yue Jia, Zun-Dong Yin, Rong Tang, Shi-Po Wu, Fu-Zhen Wang, Zhe Zhang, Hong-Xing Pan, Li Zhang, Jia-Wei Xu, Zhi-Hang Peng, Ji-Hai Tang, Qing Wang, Qing Xu, Yan Zheng, Tao Huang, Tao Li, Shu-Jun Liu, Cang-Ning Wang, Tao Zhu, Hong-Bing Shen, Wei Chen and Feng-Cai Zhu
Nanjing Medical University, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Chinese Center for Disease Control and Prevention (China CDC) - National Immunization Program, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, Chinese Center for Disease Control and Prevention (China CDC), Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Government of the People's Republic of China - Center of Disease Control and Prevention, Chongqing Center for Disease Control and Prevention, Nanjing Medical University - School of Public Health, Anhui Provincial Center for Disease Control and Prevention, Chongqing Center for Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention, Yunan Provincial Center for Disease Control and Prevention, Hunan Provincial Center for Disease Control and Prevention, Anhui Provincial Center for Disease Control and Prevention, Hunan Provincial Center for Disease Control and Prevention, Yunan Provincial Center for Disease Control and Prevention, CanSino Biologics Inc., Nanjing Medical University - Department of Epidemiology and Biostatistics, Academy of Military Medical Sciences - Institute of Biotechnology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 116 (613,149)

Abstract:

Loading...

Safety, Immunogenicity, Long-term efficacy, Aerosolized Ad5-nCoV, Booster

8.

Respiratory Pathogens Surveillance Among Infants with Acute Respiratory Illnesses: A Prospective Cohort Study, China, 2023-2024

Number of pages: 27 Posted: 24 Jul 2024
Yuqing Li, Mingwei Wei, Lun-Biao Cui, Ran Tao, Tao Wu, Suyang Qi, Baolong Wang, Xiuyun Shi, Yuanbao Liu, Wenqing Liu, Yiyue Ge, Li Chen, Xiujuan Zhao, Jingjing Wu, Runjie Qi, Xiang Huo, Feng-Cai Zhu and Jing-Xin Li
Nanjing Medical University - School of Public Health, Nanjing Medical University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Sucheng District Center for Disease Control and Prevention, Suyu District Center for Disease Control and Prevention, affiliation not provided to SSRN, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Nanjing Medical University - School of Public Health, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Siyang County Center for Disease Control and Prevent, Suyu District Center for Disease Control and Prevention, Sucheng District Center for Disease Control and Prevention, Nanjing Medical University - School of Public Health, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology and Nanjing Medical University
Downloads 80 (803,225)

Abstract:

Loading...

Acute respiratory infections, infant, respiratory pathogens surveillance, cohort study, targeted next-generation sequencing

9.

Sensitivity, Specificity and Safety of a Novel Skin Test (ESAT6-CFP10) for Tuberculosis Infection in China: Randomized, Blinded, Self-Controlled, Parallel-Group Phase 2b Trials

Number of pages: 34 Posted: 16 Mar 2020
Miao Xu, Wei Lu, Tao Li, Jingxin Li, Weixin Du, Qi Wu, Qiao Liu, Baodong Yuan, Jinbiao Lu, Xiaoyan Ding, Feng Li, Min Liu, Baowen Chen, Jiang Pu, Rongping Zhang, Xiuhong Xi, Rongguang Zhou, Zaoxian Mei, Ronghui Du, Lifeng Tao, Shui-Hua Lu, Guozhi Wang and Feng-Cai Zhu
Government of the People's Republic of China - National Institutes for Food and Drug Control, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Fudan University - Shanghai Public Health Clinical Center, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Government of the People's Republic of China - National Institutes for Food and Drug Control, Tianjin Haihe Hospital, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Wuhan Institute for Tuberculosis Control - Wuhan Pulmonary Hospital, Government of the People's Republic of China - National Institutes for Food and Drug Control, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Fudan University - Shanghai Public Health Clinical Center, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Government of the People's Republic of China - National Institutes for Food and Drug Control, Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Zhejiang Provincial Center for Disease Control and Prevention, Fudan University - Shanghai Public Health Clinical Center, Chinese Center for Disease Control and Prevention (China CDC) - Center for Disease Control and Prevention of Jurong city, Tianjin Haihe Hospital, Wuhan Institute for Tuberculosis Control - Department of Pulmonary and Critical care Medicine, Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Fudan University - Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Government of the People's Republic of China - National Institutes for Food and Drug Control and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 76 (830,555)
Citation 1

Abstract:

Loading...

10.

Safety and Immunogenicity of Ad5-Ncov Administered Intradermally By Needle-Free Injector In Rats

Number of pages: 31 Posted: 25 Jul 2024
Li Chen, Xiaoyin Zhang, Lairun Jin, Li-Hua Hou, Jing-Xin Li and Feng-Cai Zhu
Southeast University - School of Public Health, affiliation not provided to SSRN, Southeast University, Academy of Military Medical Sciences - Institute of Biotechnology, Nanjing Medical University and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 23 (1,424,331)

Abstract:

Loading...

COVID-19, adenovirus type-5 vector-based COVID-19 vaccine, immunogenicity, safety, needle-free injector